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1-year history of memory impairment. She also suffered
from anomia, spatial disorientation, and apathy. During her
clinical course, she also developed generalized epilepsy
with tonic-clonic seizures which were controlled with
phenytoin. Initial physical examination was unremarkable.
Mini-Mental State Examination (MMSE) was 14/30. Vitamin
B12, folate, thyroid function test, and Venereal Disease
Research Laboratory test were normal. A computed to-
mography (CT) brain scan showed bilateral medial temporal
lobes atrophy. Single photon emission CT (SPECT) showed
hypoperfusion over the bilateral frontal and temporopar-
ietal lobes. She fulfilled the National Institute of Neuro-
logical Communicative Disorders and Stroke-Alzheimer
Disease and Related Disorders Association (NINCDS-ADRDA)
diagnostic criteria of Alzheimer’s disease (AD). Initially,
there was no apparent family history of early onset AD
(EOAD).Conflicts of interest: The authors have no conflicts of interest
relevant to this article.
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(III1), who was 49 years old, presented with amnesia and
misplacement of personal items for 9 years (i.e., age of
onset was 40 years). She was also found to have dysex-
ecutive syndrome, anomia, dyscalculia, and apathy. Along
the clinical course, she developed depression with low
mood and suicidal ideation and was prescribed fluoxetine.
Physical examination was unremarkable. MMSE was 18/30.
A magnetic resonance imaging brain scan showed bilateral
hippocampal atrophy. SPECT showed hypoperfusion over
the left frontal, left temporoparietal lobes, and right pa-
rietal lobes. She fulfilled the NINCDS-ADRDA diagnostic
criteria of AD. She was prescribed donepezil and mem-
antine. We noted a strong family history of EOAD in this
family; the patient’s brother (II5) was initially diagnosed
with depression at 58 years old, and subsequently devel-
oped progressive amnesia with spatial disorientation,
auditory hallucination, and parkinsonism, and was finally
diagnosed with AD. Another brother (II6) suffered from
amnesic mild cognitive impairment and spatial disorienta-
tion. Genetic testing confirmed a heterozygous missense
mutation c.2149G>A (p.Val717Ile) in the amyloid precursor
protein (APP) gene in the index patient (II2) and her
daughter (III1). The family was referred for further genetic
counseling.
Our family fulfills the diagnostic criteria of familial AD
(FAD).1 It was the fourth reported FAD family with the APPAssociation. All rights reserved.
Figure 1 Pedigree of the family e squares and circles represent men and women, respectively. Affected individuals are indicated
by filled symbols and unaffected individuals by open symbols. Current age, ages at onset, and age of death are shown.
Familial Alzheimer’s disease in Chinese 1021mutation in Chinese people.2,3 Within these four families,
14 patients were affected. The mean ages of onset and
lifespan prior to death are 43  7.0 years (n Z 13) and
10.3  5.8 years (n Z 6), respectively. The mean MMSE on
presentation was 12  7.8 (n Z 3). APP mutation Val717Ile
is located near the g-secretase cleavage site and hence
increasing the production of Ab42.1 For Chinese FAD pa-
tients with the APP mutation, atypical phenotypes with
prominent psychiatric manifestations including
schizophrenic-like syndromes and behavioral and language
variants had been reported.2,3 Our family is characterized
by prominent depression and one family member presented
with prominent auditory hallucinations.
Our case illustrates that the clinician needs to pay
attention to any new family members developing cognitive
impairment, which may indicate EOAD, even when the
initial family history appears unremarkable. The diagnosis
of FAD is important, as the asymptomatic family members
can undergo genetic counseling and consider genetic
screening.1,4 An asymptomatic carrier can consider plan-
ning their personal affairs ahead and receive appropriate
treatment when they develop cognitive symptoms.Acknowledgments
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